简
/
繁
/
EN
About Us
R&D
Products
News
Careers
Investors
Contact us
Investors
（02186.HK）
HK$
➚
%
Volume(M)
0thousand
Turnover(HK $)
0thousand
Data as of：
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Year
2022
2023
2024
2025
2026
10
2023-01
Voluntary Announcement Grant of Exclusive Commercialization Rights of Boyoubei in Mainland China to CP Qingdao
09
2023-01
Voluntary Announcement Approval Obtained for Initiating Clinical Trial for the Innovative ADC Candidate BA1301 for Injection in China
06
2023-01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
29
2022-12
List of Directors and their Roles and Functions
29
2022-12
Terms of Reference of the Strategy Committee
29
2022-12
Terms of Reference of the Remuneration Committee
29
2022-12
Terms of Reference of the Nomination Committee
29
2022-12
Terms of Reference of the Audit Committee
29
2022-12
Articles of Association
29
2022-12
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
12
13
14
15
16
Follow me
鲁公网安备37069102000284